raising funds in the future to support a trial that is currently in place and near completion which will lead to Regulatory approval is easier to swallow that what we have had to in the past. But yes, the impact of cash flow from the cost and income for the trial is an unknown.
- Forums
- ASX - By Stock
- AVR
- Ann: Equity Incentive Plan
AVR
anteris technologies global corp.
Add to My Watchlist
2.50%
!
$6.15

Ann: Equity Incentive Plan, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.15 |
Change
0.150(2.50%) |
Mkt cap ! $95.31M |
Open | High | Low | Value | Volume |
$6.00 | $6.15 | $6.00 | $41.13K | 6.816K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 165 | $6.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.20 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 165 | 6.050 |
1 | 158 | 6.000 |
2 | 50025 | 5.850 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
6.550 | 1092 | 1 |
6.600 | 320 | 1 |
6.650 | 100 | 1 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |